Bariatric surgery for type 2 diabetes
- 9 June 2012
- journal article
- review article
- Published by Elsevier BV in The Lancet
- Vol. 379 (9833), 2300-2311
- https://doi.org/10.1016/s0140-6736(12)60401-2
Abstract
No abstract availableThis publication has 100 references indexed in Scilit:
- IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030Diabetes Research and Clinical Practice, 2011
- Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerolDiabetologia, 2011
- Energy intake in weight-reduced humansBrain Research, 2010
- Is the Roux Limb a Determinant for Meal Size After Gastric Bypass Surgery?Obesity Surgery, 2010
- The IDF Diabetes Atlas: Providing evidence, raising awareness and promoting actionDiabetes Research and Clinical Practice, 2010
- Health Outcomes of Gastric Bypass Patients Compared to Nonsurgical, Nonintervened Severely ObeseObesity, 2010
- Perioperative Safety in the Longitudinal Assessment of Bariatric SurgeryNew England Journal of Medicine, 2009
- Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypassInternational Journal of Obesity, 2009
- Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric bandingSurgery for Obesity and Related Diseases, 2007
- Efficacy and Safety of Incretin Therapy in Type 2 DiabetesJama-Journal Of The American Medical Association, 2007